LivaNova PLC $LIVN Shares Acquired by California State Teachers Retirement System

California State Teachers Retirement System increased its position in LivaNova PLC (NASDAQ:LIVN) by 24.3% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 63,665 shares of the company’s stock after acquiring an additional 12,447 shares during the period. California State Teachers Retirement System’s holdings in LivaNova were worth $4,047,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Hantz Financial Services Inc. grew its position in shares of LivaNova by 159.9% in the fourth quarter. Hantz Financial Services Inc. now owns 434 shares of the company’s stock valued at $27,000 after purchasing an additional 267 shares during the period. State of Wyoming acquired a new stake in LivaNova in the 2nd quarter worth about $31,000. Quarry LP acquired a new stake in LivaNova in the 3rd quarter worth about $36,000. EverSource Wealth Advisors LLC increased its stake in shares of LivaNova by 998.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 703 shares of the company’s stock valued at $32,000 after acquiring an additional 639 shares during the last quarter. Finally, Covestor Ltd increased its stake in shares of LivaNova by 108.6% during the 4th quarter. Covestor Ltd now owns 753 shares of the company’s stock valued at $46,000 after acquiring an additional 392 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Freedom Capital upgraded shares of LivaNova to a “hold” rating in a report on Tuesday, June 30th. Zacks Research upgraded shares of LivaNova from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 21st. Needham & Company LLC increased their price target on shares of LivaNova from $81.00 to $93.00 and gave the stock a “buy” rating in a research note on Wednesday. Mizuho increased their price target on shares of LivaNova from $90.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 15th. Finally, KeyCorp boosted their price objective on shares of LivaNova from $83.00 to $92.00 and gave the company an “overweight” rating in a research note on Monday, June 22nd. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, LivaNova currently has an average rating of “Moderate Buy” and a consensus price target of $83.50.

Insider Activity at LivaNova

In related news, Director Francesco Bianchi sold 1,800 shares of LivaNova stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $75.75, for a total transaction of $136,350.00. Following the transaction, the director owned 7,228 shares in the company, valued at approximately $547,521. The trade was a 19.94% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.35% of the company’s stock.

LivaNova Stock Up 0.6%

Shares of NASDAQ:LIVN opened at $76.22 on Friday. The stock has a 50-day simple moving average of $79.64 and a 200-day simple moving average of $70.75. The stock has a market capitalization of $4.20 billion, a P/E ratio of 22.55 and a beta of 0.86. LivaNova PLC has a 1 year low of $48.57 and a 1 year high of $85.76. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.11 and a current ratio of 1.45.

LivaNova (NASDAQ:LIVN) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.09 by $0.17. LivaNova had a net margin of 12.82% and a return on equity of 16.35%. The firm had revenue of $390.59 million for the quarter, compared to analyst estimates of $380.50 million. During the same quarter last year, the firm posted $1.05 earnings per share. LivaNova’s revenue for the quarter was up 10.8% compared to the same quarter last year. LivaNova has set its FY 2026 guidance at 4.300-4.400 EPS. Equities analysts forecast that LivaNova PLC will post 3.75 earnings per share for the current year.

LivaNova Company Profile

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.